Assessing Relapse in Multiple Sclerosis Questionnaire: Results of a Pilot Study
Table 5
Total Composite Score, Activities of Daily Living Score, and Return to Previous State of Health Score.
Patients Completing Part 2 of ARMS Questionnaire
value*
Total ( = 103)
Corticosteroids ( = 90)
ACTH ( = 13)
TCS after relapse, mean (SD) ( = 100†)
18.51 (7.6)
18.92 (7.4)
15.77 (8.8)
0.166
ADL score, mean (SD)
Part 1—New relapse ( = 103)
3.38 (2.1)
3.43 (2.1)
3.00 (1.9)
0.483
Part 2—After relapse treatment ( = 103)
6.21 (2.7)
6.34 (2.7)
5.31 (2.8)
0.198
Change ( = 103)
2.83 (2.8)
2.91 (2.9)
2.31 (2.4)
0.478
RSH score, mean (SD)
Part 1—New relapse ( = 90†)
7.22 (2.5)
7.33 (2.3)
6.50 (3.3)
0.283
Part 2—After relapse treatment ( = 100†)
6.00 (3.0)
6.15 (3.0)
5.00 (3.2)
0.201
Change ( = 87†)
−1.11 (2.6)
−1.03 (2.7)
−1.67 (2.2)
0.438
PCS, mean (SD)
Part 1—New relapse ( = 90†)
10.52 (3.6)
10.69 (3.4)
9.42 (4.6)
0.251
Part 2—After relapse treatment ( = 100†)
12.38 (5.2)
12.69 (5.0)
10.31 (6.0)
0.123
Change ( = 87†)
2.07 (4.4)
2.29 (4.5)
0.67 (3.4)
0.233
values based on test comparing corticosteroids and ACTH treatment groups. values for RSH and PCS are lower due to patients who did not respond to these questions in Part 1 ( = 13 patients who indicated no treatment or not sure of treatment for last relapse) or Part 2 ( = 3 patients in corticosteroids group who responded “got worse”, which was not assigned a numerical value). ACTH: adrenocorticotropic hormone; ADL: activities of daily living; ARMS: Assessing Relapse in Multiple Sclerosis; PCS: partial composite score; RSH: return to previous state of health; SD: standard deviation; TCS: total composite score.
